Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Whitney R. Buckel"'
Antibiotic prescribing for adults with group A streptococcal bacteremia in a large healthcare system
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Purpose: Limited data exist regarding treatment of invasive group A streptococcal (GAS) infections, including safety and efficacy of oral (PO) step-down therapy. We sought to describe current prescribing practices and clinical outcomes for
Externí odkaz:
https://doaj.org/article/945aeddde9974f8d80f8b825a8b43188
Autor:
Allan M. Seibert, Carly Schenk, Whitney R. Buckel, Payal K. Patel, Nora Fino, Valoree Stanfield, Adam L. Hersh, Eddie Stenehjem
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Assess urgent care (UC) clinician prescribing practices and factors associated with first-line antibiotic selection and recommended duration of therapy for sinusitis, acute otitis media (AOM), and pharyngitis. Design: Retrospec
Externí odkaz:
https://doaj.org/article/1e9ea991f3d942dbb44f87463044a5bd
Autor:
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, Preeti Khanal, Sheriza N. Baksh, Nichol McBee, Joshua Gruber, Marianne R. Gildea, Megan R. Clark, Neil A. Goldenberg, Yussef Bennani, Samuel M. Brown, Whitney R. Buckel, Meredith E. Clement, Mark J. Mulligan, Jane A. O’Halloran, Adriana M. Rauseo, Wesley H. Self, Matthew W. Semler, Todd Seto, Jason E. Stout, Robert J. Ulrich, Jennifer Victory, Barbara E. Bierer, Daniel F. Hanley, Daniel Freilich
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Background Results from observational studies and randomized clinical trials (RCTs) have led to the consensus that hydroxychloroquine (HCQ) and chloroquine (CQ) are not effective for COVID-19 prevention or treatment. Pooling individual participant da
Externí odkaz:
https://doaj.org/article/fb8cff969361400c9cf3db9a30154642
Autor:
Nick J. Tinker, Rachel A. Foster, Brandon J. Webb, Souha Haydoura, Whitney R. Buckel, Edward A. Stenehjem
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 1 (2021)
Developing and improving an antimicrobial stewardship program successfully requires evaluation of numerous factors. As technology progresses and our understanding of antimicrobial resistance grows, careful consideration should be taken to ensure that
Externí odkaz:
https://doaj.org/article/87cd50e2df3946b9bc83fce59892b5f8
Autor:
Edward Stenehjem, Anthony Wallin, Park Willis, Naresh Kumar, Allan M. Seibert, Whitney R. Buckel, Valoree Stanfield, Kimberly D. Brunisholz, Nora Fino, Matthew H. Samore, Rajendu Srivastava, Lauri A. Hicks, Adam L. Hersh
Publikováno v:
JAMA Network Open. 6:e2313011
ImportanceUrgent Care (UC) encounters result in more inappropriate antibiotic prescriptions than other outpatient setting. Few stewardship interventions have focused on UC.ObjectiveTo evaluate the effectiveness of an antibiotic stewardship initiative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0af69cf444823c3fca1036c739ab7448
https://doi.org/10.1001/jamanetworkopen.2023.13011
https://doi.org/10.1001/jamanetworkopen.2023.13011
Autor:
Emily M. Ingalls, John J. Veillette, Jared Olson, Stephanie S. May, C. Dustin Waters, Stephanie S. Gelman, George Vargyas, Mary Hutton, Nick Tinker, Gabriel V. Fontaine, Rachel A. Foster, Jena Stallsmith, Ali Earl, Whitney R. Buckel, Todd J. Vento
Publikováno v:
Hospital Pharmacy. :001857872311595
Background: Urinary tract infections (UTIs) are over-diagnosed and over-treated in the emergency department (ED) leading to unnecessary antibiotic exposure and avoidable side effects. However, data describing effective large-scale antimicrobial stewa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4201cc65555308e1203b2f336f6600
https://doi.org/10.1177/00185787231159578
https://doi.org/10.1177/00185787231159578
Autor:
Samuel M. Brown, Ithan Peltan, Naresh Kumar, Lindsay Leither, Brandon J. Webb, Nathan Starr, Colin K. Grissom, Whitney R. Buckel, Rajendu Srivastava, Allison M. Butler, Danielle Groat, Benjamin Haaland, Jian Ying, Estelle Harris, Stacy Johnson, Robert Paine, Tom Greene, Rilee Smith, Brent Armbruster, Katie Brown, Valerie Aston, Mardee Merrill, Amanda Nelson, Diana Grant, Bri Crook, Heather Maestas, Jacki Anderson, Prathyusha Kodakandla, Lisa Weaver, Jorden Greer, Macy Barrios
Publikováno v:
Annals of the American Thoracic Society
Rationale: The coronavirus disease (COVID-19) pandemic struck an immunologically naive, globally interconnected population. In the face of a new infectious agent causing acute respiratory failure for which there were no known effective therapies, rap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83530648657280460c77c4821063212a
http://europepmc.org/articles/PMC8009003
http://europepmc.org/articles/PMC8009003
Publikováno v:
Infectious Disease Clinics of North America. 34:1-15
Successful antimicrobial stewardship programs rely on engagement with hospital administrators. Antimicrobial stewards should understand the unique pressures and demands of hospital and health system administration and be familiar with key terminology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2531e803d3545eb01d7989c9bc7f4c9f
https://doi.org/10.1016/j.idc.2019.10.003
https://doi.org/10.1016/j.idc.2019.10.003
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(11)
Twenty of 21 health systems and network-based antimicrobial stewardship programs (ASPs) who were invited participated in a questionnaire, a webinar, and focus groups to understand implementation strategies for system-wide antimicrobial stewardship. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6a78c04d93f7098bb978c8783a5bc4
https://pubmed.ncbi.nlm.nih.gov/35758333
https://pubmed.ncbi.nlm.nih.gov/35758333
Autor:
Nancy Grisel, Todd J Vento, Joseph Bledsoe, Brandon J. Webb, Eddie Stenehjem, Theadora Sakata, Mark B. Shah, Ithan D. Peltan, Emily S Spivak, Samuel M. Brown, Anthony Wallin, Greg Poulsen, Whitney R. Buckel, Allison M. Butler
Publikováno v:
Open Forum Infectious Diseases
Background Neutralizing monoclonal antibodies (MAbs) are a promising therapy for early coronavirus disease 2019 (COVID-19), but their effectiveness has not been confirmed in a real-world setting. Methods In this quasi-experimental pre-/postimplementa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b671c82730fcdab795a855fcf1c28dfa
https://doi.org/10.1093/ofid/ofab331
https://doi.org/10.1093/ofid/ofab331